Contrast agents for myocardial perfusion imaging
AssigneeLantheus Medical Imaging, Inc.
InventorsHeike S. Radeke, David S. Casebier, Michael T. Azure, Douglas D. Dischino
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed, in part, to compounds and methods for imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging.
Claims23
A contrast agent comprising an imaging moiety and a compound selected from an annonaceous acetogenin, a quinone acetogenin, a substituted chromone, and an open-chain deguelin analog.
7-10. (canceled)
(canceled)
16-21. (canceled)
23-24. (canceled)
A method of imaging myocardial perfusion comprising administering to a patient a contrast agent which comprises an imaging moiety and a compound selected from an annonaceous acetogenin, a quinone acetogenin, a substituted chromone and an open-chain deguelin analog;
- and scanning the patient using diagnostic imaging.
Dependencies are inferred from the claim text.